Thymoma-associated Graft-versus-Host Disease-like Erythroderma  by Nakagiri, Tomoyuki et al.
CASE REPORT
Thymoma-associated Graft-versus-Host
Disease-like Erythroderma
Tomoyuki Nakagiri, MD,* Meinoshin Okumura, MD, PhD,* Masayoshi Inoue, MD, PhD,*
Masato Minami, MD, PhD,* Eiji Kiyohara, MD,† Noriko Umegaki, MD, PhD,†
Toshiaki Nakamura, MD, PhD,† Yasuhiko Tomita, MD, PhD,‡ Ichirou Katayama, MD, PhD,†
and Katsuyuki Aozasa, MD, PhD‡
We report a 40-year-old woman with recurrent thymoma associated
with myasthenia gravis, in whom an unusual form of erythroderma
developed. A histological examination revealed a graft-versus-host
disease (GVHD)-like reaction. After high-dose steroid therapy, the
metastatic thymoma lesion in the abdominal cavity was reduced in
size from 9.5  6  7.5 cm to 4  3  1 cm in diameter.
Nevertheless, the GVHD-like erythroderma become aggravated, her
condition worsened, and the patient finally suffered from respiratory
failure and died of sepsis. A GVHD-like reaction may be a rare
presentation of thymoma-associated immunological disorders such
as myasthenia gravis or pure red cell aplasia. Herein, we discuss the
present case and review pertinent reports of thymoma cases associ-
ated with GVHD.
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Thymomas are frequently associated with autoimmune dis-eases such as myasthenia. Acute graft-versus-host disease
(GVHD), an abnormal immunological condition, occasion-
ally occurs in the setting of bone marrow transplantation after
high-dose chemotherapy and transfusion, or transplantation
of solid organs containing lymphoid tissue. Herein, we report
a patient with recurrent thymoma, in whom GVHD-like
erythroderma developed.
CASE REPORT
A 23-year-old woman underwent an extended thymec-
tomy for generalized myasthenia gravis in 1987. A histo-
logical examination at the time revealed a thymoma in-
volving the capsule of the tumor, indicating Masaoka stage
II disease. The thymoma was classified as type B1 accord-
ing to the World Health Organization histological classi-
fication system.
In 1998, severe general symptoms of myasthenia gravis
recurred. Then, recurrence of thymoma was not identified by
computed tomography scan when symptoms of myasthenia
gravis relapsed. Nevertheless, those symptoms were not re-
lieved by steroid therapy, and immunosuppressive treatment
with tacrolimus was introduced in the same year. After
beginning tacrolomus therapy, those symptoms were miti-
gated. In 2002, multiple tumors appeared in the left pleural
cavity and were resected. One of those lesions had penetrated
the diaphragm; thus, tumor resection was performed along
with partial resection of the diaphragm. Two years later,
multiple recurrent tumors appeared in the peritoneal cavity.
Chemotherapy with carboplatin and paclitaxel was not effec-
tive, and thus an ovarian tumor was suspected. Subtotal
resection of the peritoneal tumors with bilateral oophorec-
tomy was performed, and a large tumor, 9.5  6.0  7.4 cm
in size, was found behind the liver; it had metastasized from
the thymoma. For mass reduction and relief of myasthenia
gravis, steroid pulse therapy instead of tacrolimus was started
in 2005.
A few days after beginning steroid therapy, erythro-
derma appeared in the trunk and extremities without other
clinical symptoms, and test results were negative for sev-
eral virus antibodies, except herpes simplex virus 1, which
was positive (30.1) before beginning therapy. Further, no
bacteria were found in the epidermis, and the patient did
not have any lesions specific to Stevens–Johnson syn-
drome, so this disorder was ruled out. In addition, a
histological examination of a biopsy specimen from the
skin revealed parakeratosis in the epidermal layer, with a
number of apoptotic bodies accompanied by lymphocytic
infiltration, suggesting the development of acute, GVHD-
like reaction (Figure 1). Immunohistochemical staining
also revealed that the infiltrated T cells were predomi-
nantly CD8, whereas keratinocytes expressing HLA-
DR and CD1a were occasionally intermingled. The
clinical course and histological and immunohistochemical
findings justified the diagnosis of GVHD-like erythro-
derma. Although high-dose oral steroid therapy, combined
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with immunosuppressive therapy with cyclosporine A, was
given, the condition was not resolved. During the high-
dose steroid therapy, erythroderma with vesicles and ul-
cers appeared (Figure 2); this may have been caused by the
herpes simplex infection, because the skin had phlyctenula
with deep red areolas like varicella, as in aposi’s varicel-
liform eruption. Nevertheless, the other virus antibodies
remained negative, and the other skin lesions could not
have occurred from herpes simplex 1 alone. Therefore, we
continued therapy against GVHD-like reaction. Interest-
ingly, the abdominal tumor was remarkable reduced in size
along with the intensified acute GVHD-like reaction,
whereas the erythroderma became more severe. Erythro-
derma was mitigated 2 months after beginning the therapy.
Weaning of steroid was intended, but the erythroderma
appeared again, and myasthenic crisis also developed.
Tracheal intubation was performed, and artificial respira-
tion was started. Finally, the patient suffered from respi-
ratory failure and died of sepsis 5 months after the appear-
ance of the erythroderma. An autopsy was subsequently
performed.
Histologically, hyperkeratosis and parakeratosis with
spongiotic change and apoptotic cells were found over the
epidermal layer. In addition, a bandlike infiltration, exocyto-
sis of lymphocytes, and dense, perivascular, lymphocytic
infiltrations were observed at the dermoepidermal junction
(Figure 3). Immunohistochemical staining revealed that the
lymphocytes infiltrating the epidermis were predominantly
CD8 T cells accompanied by a few CD4 T cells. The
tumor was present on the liver and was sized 4  3  1 cm,
with histological results showing it to be a type B2 thymoma.
A thorough histological examination did not reveal a GVHD-
like reaction in other organs. These findings confirmed the
diagnosis of GVHD-like erythroderma, which developed dur-
ing treatment for recurrent thymoma.
DISCUSSION
Thymomas are well known for their frequent asso-
ciation with paraneoplastic autoimmune diseases, includ-
ing myasthenia gravis, pure red cell aplasia, and acquired
hypogammaglobulinemia. Nevertheless, the mechanism
for the development of several autoimmune disorders as-
sociated with thymomas has not been fully elucidated.
Several studies have suggested the possible role of neo-
plastic epithelial cells present in the thymoma for induc-
tion of autoreactive T cells. Further, CD4CD8 T cells,
the typical phenotype of normal cortical thymocytes, are
abundant in thymic tissue, indicating that neoplastic epi-
thelial cells in the tumor are able to retain the function of
the thymic cortex for induction of T cell development. On
the other hand, the expression level of HLA-DR molecules
in thymoma cells is decreased compared with that of
normal thymic epithelial cells. In addition, a normal thy-
mic structure, in which autoreactive T cells are considered
eliminated, might be absent in thymoma tissues. These
observations have led to the notion that alternated T cell
development and selection in thymomas might be respon-
sible for the development of autoimmunity.
GVHD is an abnormal immunological condition
caused by the activation of donor T cells that show clonal
expansion after transfusion or bone marrow transplanta-
tion.1 The present patient did not have a history of trans-
plantation. Further, all transfused blood was pretreated
with radiation, which is considered to prevent GVHD.
Thus, exogenous causes for GVHD-like symptoms in this
patient seem to be unlikely, and a drug-induced allergy or
infection could also be ruled out by the medication history
and laboratory data.
Several cases of GVHD-like reaction associated with a
thymoma have been reported (Table 1).2–7 The findings in
those reports, together with those of the present case, suggest
that autoreactive T cells derived from thymomas play a role
in the development of GVHD-like reactions.
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FIGURE 1. Histopathological examination findings revealed
perivascular lymphocytic infiltration in the dermis (arrow 1),
as well as parakeratosis (arrow 2), apoptosis, and satellite cell
necrosis (arrow 3) in the epidermis. Hematoxylin and eosin
stain (weak magnification).
FIGURE 2. Keratotic erythroderma, vesicles, and ulcers in
the skin. (The picture was colored.)
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FIGURE 3. Hyperkeratosis and parakerato-
sis (arrow 1) in the epidermal layer with a
number of spongiotic and dyskeratotic cells.
Bandlike infiltration and exocytosis of lym-
phocytes (arrow 2), along with perivascular,
lymphocytic infiltration (arrow 3), can be
seen at the dermoepidermal junction.
TABLE 1. Reported Cases of Graft-versus-Host Disease–like Reaction in
Association with Thymoma
Case Age/Gender Symptom Complication Outcome
1, (2) 57/female Diarrhea Hypo-gGlb Died
Erythema multiforme
Jaundice
2, (3) 38/female Maculoerythematous rash MG Died
Liver dysfunction
Diarrhea
3, (4) 47/male Maculoerythematous rash Hypo-gGlb Alive (7 mo)
Diarrhea PRCA
4, (5) 46/female Erythroderma desquamatuva None Died (8 mo)
5, (6) 46/male Diarrhea None Alive
6, (7) 20/male Diarrhea None Alive (2 yr)
The reference number is listed next to the case number in parentheses. Hypo-gGlb, hypogammaglobu-
linemia; MG, myasthenia gravis; PRCA, pure red cell aplasia.
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